The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prospective observational study on chemotherapy-induced nausea and vomiting (CINV) for hepatobiliary and pancreatic cancer patients who were to receive chemotherapy including cisplatin by the CINV study group of Japan.
Junji Furuse
Honoraria - Taiho Pharmaceutical
Research Funding - Ono Pharmaceutical ; Taiho Pharmaceutical
Hideo Baba
Honoraria - Ono Pharmaceutical
Research Funding - Ono Pharmaceutical
Shinichi Ohkawa
No relevant relationships to disclose
Kazuya Sugimori
No relevant relationships to disclose
Kazuhide Yamamoto
No relevant relationships to disclose
Hironobu Minami
Honoraria - Chugai Pharma; Ono Pharmaceutical ; Taiho Pharmaceutical
Research Funding - Chugai Pharma; Ono Pharmaceutical ; Taiho Pharmaceutical
Yuko Kitagawa
Honoraria - Ono Pharmaceutical
Research Funding - Ono Pharmaceutical
Hidekazu Kuramochi
No relevant relationships to disclose
A-Hon Kwon
No relevant relationships to disclose
Michiaki Unno
No relevant relationships to disclose
Go Wakabayashi
No relevant relationships to disclose
Keisuke Aiba
Honoraria - Ono Pharmaceutical ; Taiho Pharmaceutical
Kazuo Tamura
No relevant relationships to disclose